CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 73 filers reported holding CUE BIOPHARMA INC in Q2 2024. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $938,353 | -77.9% | 756,736 | -66.3% | 0.00% | – |
| Q1 2024 | $4,241,354 | -31.3% | 2,244,103 | -4.0% | 0.00% | – |
| Q4 2023 | $6,174,340 | +26.1% | 2,338,765 | +9.9% | 0.00% | – |
| Q3 2023 | $4,896,585 | -35.1% | 2,128,950 | +3.0% | 0.00% | – |
| Q2 2023 | $7,541,171 | +217.9% | 2,066,074 | +211.0% | 0.00% | – |
| Q1 2023 | $2,372,000 | +18.5% | 664,426 | -5.4% | 0.00% | – |
| Q4 2022 | $2,001,217 | +15.2% | 702,181 | -9.8% | 0.00% | – |
| Q3 2022 | $1,737,000 | -16.2% | 778,708 | -6.4% | 0.00% | – |
| Q2 2022 | $2,072,000 | -82.2% | 831,925 | -65.1% | 0.00% | – |
| Q1 2022 | $11,622,000 | -55.1% | 2,381,267 | +4.0% | 0.00% | -100.0% |
| Q4 2021 | $25,903,000 | -17.7% | 2,290,269 | +6.0% | 0.00% | 0.0% |
| Q3 2021 | $31,476,000 | +25.7% | 2,160,458 | +0.5% | 0.00% | 0.0% |
| Q2 2021 | $25,034,000 | -8.7% | 2,148,798 | -4.4% | 0.00% | 0.0% |
| Q1 2021 | $27,422,000 | +1.3% | 2,247,704 | +3.9% | 0.00% | 0.0% |
| Q4 2020 | $27,059,000 | -15.0% | 2,162,978 | +2.2% | 0.00% | 0.0% |
| Q3 2020 | $31,841,000 | -32.8% | 2,115,645 | +9.5% | 0.00% | -50.0% |
| Q2 2020 | $47,349,000 | +151.0% | 1,931,756 | +45.3% | 0.00% | +100.0% |
| Q1 2020 | $18,865,000 | -14.4% | 1,329,428 | -4.2% | 0.00% | 0.0% |
| Q4 2019 | $22,029,000 | +114.0% | 1,387,669 | +13.6% | 0.00% | – |
| Q3 2019 | $10,295,000 | -0.3% | 1,221,270 | +6.4% | 0.00% | – |
| Q2 2019 | $10,321,000 | +41.1% | 1,148,126 | +21.3% | 0.00% | – |
| Q1 2019 | $7,314,000 | +72.4% | 946,140 | +4.8% | 0.00% | – |
| Q4 2018 | $4,243,000 | -48.4% | 902,906 | -0.6% | 0.00% | – |
| Q3 2018 | $8,222,000 | -21.4% | 908,512 | +3.0% | 0.00% | – |
| Q2 2018 | $10,461,000 | +88.6% | 881,959 | +123.4% | 0.00% | – |
| Q1 2018 | $5,547,000 | – | 394,827 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 829,042 | $9,376,000 | 5.61% |
| P.A.W. CAPITAL CORP | 120,000 | $1,357,000 | 1.24% |
| Nantahala Capital Management | 2,539,700 | $28,724,000 | 1.01% |
| Slate Path Capital LP | 1,483,619 | $16,780,000 | 0.88% |
| SANDERS MORRIS HARRIS LLC | 359,113 | $4,416,000 | 0.76% |
| APOGEM CAPITAL LLC | 62,295 | $705,000 | 0.46% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $5,411,000 | 0.46% |
| Bleichroeder LP | 200,000 | $2,262,000 | 0.35% |
| ADVISORY RESEARCH INC | 257,225 | $2,909,000 | 0.23% |
| Granite Point Capital Management, L.P. | 110,000 | $1,244,000 | 0.21% |